Telomerase and idiopathic pulmonary fibrosis

被引:167
|
作者
Armanios, Mary [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
Dyskeratosis congenita; Interstitial lung disease; Aplastic anemia; Liver cirrhosis; Emphysema; Diabetes; DOMINANT DYSKERATOSIS-CONGENITA; STEM-CELL TRANSPLANTATION; BONE-MARROW FAILURE; REVERSE-TRANSCRIPTASE; TERMINAL TRANSFERASE; APLASTIC-ANEMIA; MUTATIONS; RNA; TETRAHYMENA; EMPHYSEMA;
D O I
10.1016/j.mrfmmm.2011.10.013
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Idiopathic pulmonary fibrosis (IPF) is the most common manifestation of telomere-mediated disorders. Germline mutations in the essential telomerase genes, hTERT and hTR, are the causal genetic defect in up to one-sixth of pulmonary fibrosis families. The presence of telomerase mutations in this subset is significant for clinical decisions as affected individuals can develop extra-pulmonary complications related to telomere shortening such as bone marrow failure and cryptogenic liver cirrhosis. There is also evidence that IPF is an ancestral manifestation of autosomal dominant telomere syndromes where, with successive generations, the disease evolves from pulmonary fibrosis into a bone marrow failure-predominant disorder, defining a unique form of genetic anticipation. Here I review the significance of telomere defects for understanding the genetics, disease patterns and pathophysiology of IPF. The importance of this diagnosis for patient care decisions will also be discussed. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 50 条
  • [31] Telomerase expression in idiopathic pulmonary fibrosis (IPF) and non small cell lung cancer (NSCLC)
    Samara, Katerina
    Lasithiotaki, Ismini
    Soufla, Giannoula
    Giannarakis, Ioannis
    Velivassaki, Maria
    Psaraki, Anna
    Siafakas, Nikolaos
    Antoniou, Katerina
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [32] Distribution of emphysema and fibrosis in idiopathic pulmonary fibrosis with coexisting emphysema
    Kinoshita, Yoshiaki
    Watanabe, Kentaro
    Ishii, Hiroshi
    Kushima, Hisako
    Fujita, Masaki
    Nabeshima, Kazuki
    HISTOPATHOLOGY, 2019, 74 (07) : 1103 - 1108
  • [33] Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema
    Jacob, Joseph
    Bartholmai, Brian J.
    Rajagopalan, Srinivasan
    Karwoski, Ronald
    Nair, Arjun
    Walsh, Simon L. F.
    Barnett, Joseph
    Cross, Gary
    Judge, Eoin P.
    Kokosi, Maria
    Renzoni, Elisabetta
    Maher, Toby M.
    Wells, Athol U.
    RESPIROLOGY, 2018, 23 (06) : 593 - 599
  • [34] Molecular Mechanisms in Progressive Idiopathic Pulmonary Fibrosis
    Steele, Mark P.
    Schwartz, David A.
    ANNUAL REVIEW OF MEDICINE, VOL 64, 2013, 64 : 265 - 276
  • [35] Small airway dysfunction in idiopathic pulmonary fibrosis
    Yin, Chengsheng
    Xie, Huikang
    He, Xian
    Zhang, Yuan
    Zhang, Aihong
    Li, Huiping
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis
    Kurashima, Kazuyoshi
    Takayanagi, Noboru
    Tsuchiya, Noriko
    Kanauchi, Tetsu
    Ueda, Miyuki
    Hoshi, Toshiko
    Miyahara, Yosuke
    Sugita, Yutaka
    RESPIROLOGY, 2010, 15 (05) : 843 - 848
  • [37] Idiopathic Pulmonary Fibrosis: CT and Risk of Death
    Ley, Brett
    Flicker, Brett M.
    Hartman, Thomas E.
    Ryerson, Christopher J.
    Vittinghoff, Eric
    Ryu, Jay H.
    Lee, Joyce S.
    Jones, Kirk D.
    Richeldi, Luca
    King, Talmadge E., Jr.
    Collard, Harold R.
    RADIOLOGY, 2014, 273 (02) : 570 - 579
  • [38] Progress in Understanding and Treating Idiopathic Pulmonary Fibrosis
    Kropski, Jonathan A.
    Blackwell, Timothy S.
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 211 - 224
  • [39] Prognosis of acute exacerbation in idiopathic pulmonary fibrosis with pulmonary emphysema: a retrospective cohort study in Japan
    Horio, Yukihiro
    Takihara, Takahisa
    Takahashi, Fuminari
    Enokida, Keito
    Nakamura, Noriko
    Tanaka, Jun
    Tomomatsu, Katsuyoshi
    Niimi, Kyoko
    Tajiri, Sakurako
    Hayama, Naoki
    Ito, Yoko
    Oguma, Tsuyoshi
    Asano, Koichiro
    BMJ OPEN, 2022, 12 (09):
  • [40] Increased fibroblast telomerase expression precedes myofibroblast α-smooth muscle actin expression in idiopathic pulmonary fibrosis
    Waisberg, Daniel Reis
    Parra, Edwin Roger
    Barbas-Filho, Joao Valente
    Fernezlian, Sandra
    Capelozzi, Vera Luiza
    CLINICS, 2012, 67 (09) : 1039 - 1046